Lilly Enters into Exclusive Licensing Agreement with Rigel Pharmaceuticals Accessing Promising RIPK1 Inhibitor
Eli Lilly and Co inked a deal to gain worldwide, exclusive licensing rights to the autoimmune and inflammatory disease treatment […]
German Investor Christain Angermayer Lists SPAC with Biotech Focus
German investor Christian Angermayer is planning to list a blank-cheque company in New York. His Frontier Acquisition Corp., a special […]
UK to Conduct World’s First Human Challenge COVID-19 Trials—Deliberate Infection of Volunteers
Back in October 2020, the United Kingdom government announced an investment of 33.6 million pounds ($43.5 million) in what’s known […]
A New Paradigm for Patient Recruitment: Leveraging Medical Laboratory Data for Patient Recruitment
Cerba Research, a leading healthcare diagnostic company and wholly owned subsidiary of Cerba Healthcare, today announced a new partnership with […]
Fred Hutch & UW Spinoff Ensoma Secures $70m to Pioneer Next Generation In Vivo Approach to Delivery First “Off-the-shelf” Genomic Medicines
A new biotech venture called Ensoma was launched just recently, in conjunction with a sizable $70 million Series A funding […]
Day One Biopharma Announces $130 Million Series B Financing to Advance Targeted Cancer Treatments for Children
Day One Biopharmaceuticals announced the closing of a $130 million Series B financing, led by RA Capital Management with participation […]
Notch Therapeutics Closes $85 Million Series A for Pipeline of Renewable Stem Cell-Derived Cancer Immunotherapies
Notch Therapeutics announced the closing of an oversubscribed $85 million Series A financing, led by an exclusively healthcare-focused investment fund. […]
Pipeline Therapeutics Closes $80M Series C to Advance First-in-Class Small Molecules for Neuroregeneration
Pipeline Therapeutics announced the closing of an $80 million Series C financing. The oversubscribed financing was led by a healthcare-focused […]
Anti-Aging Distributed Drug Discovery Venture Cambrian Biopharma Announces $60m Funding & First IPO of Portfolio Company
The last decades’ technological, business and social and economic breakthroughs have created unprecedented wealth worldwide. With about 50 million millionaires around […]
Inhalable Remdesivir at Contacts or Early Onset Could Generate Large Growth for Remdesivir—Still in Early Stages Investigation
Gilead’s inhaled version of remdesivir (Veklury) could add considerable value to the COVID-19 market. Potentially, the drug could be used […]
